Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients

A. Rios, D. A. Stringfellow, F. A. Fitzpatrick, S. B. Reele, G. D. Gutknecht, Evan M Hersh

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)330-338
Number of pages9
JournalJournal of Biological Response Modifiers
Volume5
Issue number4
StatePublished - 1986
Externally publishedYes

Fingerprint

Pyrimidinones
Interferon Inducers
Drug Evaluation
Cytosine
Immunologic Factors
Interferons
Melanoma
Neoplasms
Pharmaceutical Preparations
Antineoplastic Agents
Nausea
Abdominal Pain
Biological Availability
Vomiting
Headache
Diarrhea
Animal Models
Kidney
4(3H)-pyrimidinone
Liver

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Immunology

Cite this

Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients. / Rios, A.; Stringfellow, D. A.; Fitzpatrick, F. A.; Reele, S. B.; Gutknecht, G. D.; Hersh, Evan M.

In: Journal of Biological Response Modifiers, Vol. 5, No. 4, 1986, p. 330-338.

Research output: Contribution to journalArticle

Rios, A. ; Stringfellow, D. A. ; Fitzpatrick, F. A. ; Reele, S. B. ; Gutknecht, G. D. ; Hersh, Evan M. / Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients. In: Journal of Biological Response Modifiers. 1986 ; Vol. 5, No. 4. pp. 330-338.
@article{37115da32684493891bd0ad89f2aa5dc,
title = "Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients",
author = "A. Rios and Stringfellow, {D. A.} and Fitzpatrick, {F. A.} and Reele, {S. B.} and Gutknecht, {G. D.} and Hersh, {Evan M}",
year = "1986",
language = "English (US)",
volume = "5",
pages = "330--338",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients

AU - Rios, A.

AU - Stringfellow, D. A.

AU - Fitzpatrick, F. A.

AU - Reele, S. B.

AU - Gutknecht, G. D.

AU - Hersh, Evan M

PY - 1986

Y1 - 1986

UR - http://www.scopus.com/inward/record.url?scp=0023029816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023029816&partnerID=8YFLogxK

M3 - Article

C2 - 2426417

AN - SCOPUS:0023029816

VL - 5

SP - 330

EP - 338

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 4

ER -